This study not only confirms the observation made in the SOD1G93A mouse model on the implication of the IFNγ/LIGHT/LT-βR death pathway in ALS, but also it further extrapolates these findings to a larger number of clinical cases, with sporadic ALS patients showing signs of activation of this death pathway. Here, IFNG is linked to amyotrophic lateral sclerosis.